June 2023

A Belfast-based business behind a software platform which helps streamline the work of surveyors has been acquired by ScaleUp Capital.

Established in 2011, GoReport identified a void in the market for software which helps surveyors digitise their inspecting, reporting and analysis process. GoReport provides software which support surveys and inspections in the residential and commercial sector and is used by a range of clients to support the transition towards digital workflows, enabling surveyors to focus […]

A Belfast-based business behind a software platform which helps streamline the work of surveyors has been acquired by ScaleUp Capital. Read More »

Congratulations to portfolio company, PlotBox, and its senior team Sean McAllister and Leona McAllister on securing significant investment from Guinness Ventures and other existing investors.

The new investment will support PlotBox‘s strategy for global growth and expansion, enabling its continued development of best-in-class products and services that will help to revolutionise the way deathcare facilities both operate and grow. Pictured above: Leona McAllister and Sean McAllister (Joint CEO’s) PlotBox, the leading software solutions provider to cemeteries and crematoria, has announced a

Congratulations to portfolio company, PlotBox, and its senior team Sean McAllister and Leona McAllister on securing significant investment from Guinness Ventures and other existing investors. Read More »

invoX Pharma has completed a second tranche of investment into portfolio company, pHion Therapeutics, a next-generation mRNA vaccine company.

Congratulations to Helen McCarthy, Darach Neeson, and the rest of the pHion Therapeutics team, as well as Ben Toogood at invoX Pharma Limited. We look forward to continuing to support the company, along with QUBIS Ltd and other investors, on its exciting growth journey. Article taken from: https://finance.yahoo.com/ LONDON, June 01, 2023–(BUSINESS WIRE)–invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino

invoX Pharma has completed a second tranche of investment into portfolio company, pHion Therapeutics, a next-generation mRNA vaccine company. Read More »

Congratulations to portfolio company, Cumulus Neuroscience, on completing patient enrolment.

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-stage Alzheimer’s Dementia Validation Trial. Article taken from: https://cumulusneuro.com/articles/2023_05_31/ We are pleased to announce the completion of patient enrollment for our CNS-101 multi-site study. The real-world study evaluates the feasibility of using repeated sampling of validated digital measures at home in patients with early-stage Alzheimer’s disease (AD), compared with

Congratulations to portfolio company, Cumulus Neuroscience, on completing patient enrolment. Read More »